TY  - CONF
AU  - Lewis, Karl
AU  - Ascierto, Paolo
AU  - Robert, Caroline
AU  - Munhoz, Rodrigo
AU  - Liszkay, Gabriella
AU  - De La Cruz Marino, Luis
AU  - Olah, Judit
AU  - Queirolo, Paola
AU  - Mackiewicz, Jacek
AU  - Shah, Kalpit
AU  - Forbes, Harper
AU  - Hertig, Christian
AU  - Yan, Yibing
AU  - Gutzmer, Ralf
AU  - McArthur, Grant
PY  - 2020
DO  - 10.1136/jitc-2020-SITC2020.0307
UR  - https://hdl.handle.net/10668/27584
T2  - Journal for immunotherapy of cancer
LA  - en
PB  - Bmj publishing group
TI  - ATEZOLIZUMAB PLUS VEMURAFENIB AND COBIMETINIB PROVIDES FAVORABLE SURVIVAL OUTCOMES IN PATIENTS WITH HIGH TUMOR MUTATION BURDEN AND PROINFLAMMATORY GENE SIGNATURE IN THE PHASE 3 IMSPIRE150 STUDY
TY  - conference output
VL  - 8
ER  -